Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-04-22 @ 4:50 AM
Study NCT ID:
NCT02717156
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-05
First Post:
2016-03-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors
Sponsor:
University of Southern California
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-21
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-17
First Submit QC Date:
None
Study First Post Date:
2016-03-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-04
Last Update Post Date:
2025-06-05
Last Update Post Date Type:
ACTUAL